Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Point Of Care Infectious Disease Testing Market Size From 2025 to 2034?
In recent times, the market size for point of care infectious disease testing has seen notable growth. The market, which is expected to expand from $4.21 billion in 2024 to $4.78 billion, will do so with a compound annual growth rate (CAGR) of 13.6% in 2025. Fueling this historical growth period is the rising demand for swift diagnostic services, the increasing occurrence of infectious diseases, heightened healthcare consciousness, growing healthcare expenses and the upswing in the usage of home care and self-testing options.
Anticipations are high for a swift expansion of the point of care infectious disease testing market in the years to come, with estimations suggesting a rise to$7.96 billion in 2029 showcasing a compound annual growth rate (CAGR) of 13.6%. This projected growth within the stipulated period can be associated with factors such as the upsurge in the need for swift diagnosis, higher occurrences of infectious diseases, increased utilization in remote and resource-deficient areas, a transition towards more localized healthcare, and the introduction of favourable government schemes and funding. Key trends expected during this forecast window encompass progress in molecular diagnostics, improved point of care testing gadgets, evolution in biosensors and detection techniques, strides in mobile health applications, and inventive collaborations between healthcare practitioners and technology organizations.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24382&type=smp
What Are the Core Growth Drivers Propelling the Point Of Care Infectious Disease Testing Market Forward?
The expanding influence of communicable diseases is anticipated to drive the expansion of the point of care infectious disease testing market. Communicable diseases, those that can be transferred from person to person in various ways including direct contact and airborne droplets, are on the rise due to increased human mobility. As people traverse different regions and nations more freely, the spread of infectious agents becomes quicker and broader. Point of care testing for infectious diseases speeds up the identification and diagnosis of these diseases, allowing for prompt treatment and minimising further spread within populations. As an example, the UK Health Security Agency reported in June 2024 that between week 40 of 2022 and week 15 of 2023, 108 NHS trusts in England counted 1,681 critical care admissions owing to confirmed cases of influenza. This compares to just 182 admissions across 114 trusts in the prior flu season, which had risen to 316 by week 39 of 2022. As a result, the growing incidence of communicable diseases is fueling the expansion of the point of care infectious disease testing market.
What Segment Types Define the Point Of Care Infectious Disease Testing Market Structure?
The point of care infectious disease testingmarket covered in this report is segmented –
1) By Product: Kits And Reagents; Instruments
2) By Technology: Lateral Flow Immunoassay; Agglutination Test; Flow-through Test Or Immunoconcentration Assay; Molecular Diagnostics; Other Technologies
3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing; Clostridium Difficile Point-of-Care Testing; Hepatitis B Virus Point-of-Care Testing; Pneumonia or Streptococcus Associated Infections; Respiratory Syncytial Virus Point-of-Care Testing; Human Papillomavirus Point-of-Care Testing; Influenza Or Flu Point-of-Care Testing; Other Diseases
4) By End Use: Hospitals; Diagnostic Centers; Research and Academic Institutes; Homecare Settings; Other End Users
Subsegments:
1) By Kits And Reagents: Test Kits; Reagents
2) By Instruments: Portable Devices; Automated Analyzers
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24382&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Point Of Care Infectious Disease Testing Market?
North America was the largest region in the point of care infectious disease testing market in 2024. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in the point of care infectious disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing thePoint Of Care Infectious Disease Testing Industry Evolution?
Leading businesses in the point-of-care infectious disease testing market are concentrating on incorporating groundbreaking technologies like proprietary microfluidic technology. This takes the testing accuracy, swiftness of results, and patient outcomes up a notch. Proprietary microfluidic technology involves distinct systems that handle tiny fluid amounts on a microscopic scale. This allows for a quick, exact, and affordable analysis that benefits point of care (POC) infectious disease testing. It does this by making possible speedy pathogen identification on-site with integrated sample collection, scrutiny, and results, thereby increasing speed and accessibility of diagnoses without requiring centralized lab testing. For example, in June 2023, Sysmex Corporation, a diagnostics firm from Japan, launched the PA-100 AST System in Europe, marking the first global point-of-care testing solution for immediate antimicrobial susceptibility detection. Through the utilization of revolutionary microfluidic technology, the system expedites the identification of bacterial infections and the evaluation of antimicrobial effectiveness. This slashes the processing time in comparison to traditional methods. It comprises a compact, desktop-sized analyzer and single-use sample cartridges, rendering it suitable for near-patient environments like primary care clinics. Developed to aid swifter and more precise antimicrobial therapy determinations, the system aids the worldwide initiative to defeat antimicrobial resistance by boosting diagnostic effectiveness.
View the full report here:
What Is the Definition of the Point Of Care Infectious Disease Testing Market?
Point of care (POC) infectious disease testing refers to diagnostic tests that are performed at or near the site of patient care, such as hospitals, clinics, doctors’ offices, or even at home. These tests are designed to detect infectious diseases quickly and accurately, providing immediate results to facilitate prompt treatment decisions. POC tests are typically user-friendly, require minimal equipment, and offer results within minutes to hours, making them ideal for situations where timely diagnosis is crucial.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24382
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model